Ticagrelor Induced Angioedema Following Carotid Artery Stenting
- PMID: 35755229
- PMCID: PMC9214928
- DOI: 10.1177/19418744221097353
Ticagrelor Induced Angioedema Following Carotid Artery Stenting
Abstract
Ticagrelor is a frequent component of dual antiplatelet therapy (DAPT) following carotid artery stent placement. Hemorrhagic complications remain the focus of most reports, however, other adverse events must also be known to the prescribing physician. Angioedema is a rare and potentially life-threatening complication reported following ticagrelor administration and we present 1 such case here with a review of the existing literature.
Keywords: angioedema; carotid stenting; stroke; ticagrelor.
© The Author(s) 2022.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- Held C, Åsenblad N, Bassand JP, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: Results from the PLATO (platelet inhibition and patient outcomes) trial. J Am Coll Cardiol. 2011;57(6):672-684. doi:10.1016/j.jacc.2010.10.029 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources